Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2049961720;61721;61722 chr2:178590230;178590229;178590228chr2:179454957;179454956;179454955
N2AB1885856797;56798;56799 chr2:178590230;178590229;178590228chr2:179454957;179454956;179454955
N2A1793154016;54017;54018 chr2:178590230;178590229;178590228chr2:179454957;179454956;179454955
N2B1143434525;34526;34527 chr2:178590230;178590229;178590228chr2:179454957;179454956;179454955
Novex-11155934900;34901;34902 chr2:178590230;178590229;178590228chr2:179454957;179454956;179454955
Novex-21162635101;35102;35103 chr2:178590230;178590229;178590228chr2:179454957;179454956;179454955
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: CGA
  • RefSeq wild type template codon: GCT
  • Domain: Ig-121
  • Domain position: 21
  • Structural Position: 34
  • Q(SASA): 0.5365
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/Q rs201286988 -0.212 0.844 N 0.536 0.22 None gnomAD-2.1.1 3.03E-05 None None None None N None 6.57E-05 3.11E-05 None 0 5.69E-05 None 0 None 0 3.77E-05 0
R/Q rs201286988 -0.212 0.844 N 0.536 0.22 None gnomAD-4.0.0 3.11903E-05 None None None None N None 0 2.33318E-05 None 0 0 None 1.90078E-05 0 3.80906E-05 0 1.68011E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.5839 likely_pathogenic 0.6038 pathogenic 0.07 Stabilizing 0.345 N 0.533 neutral None None None None N
R/C 0.322 likely_benign 0.3098 benign -0.038 Destabilizing 0.991 D 0.575 neutral None None None None N
R/D 0.8504 likely_pathogenic 0.8519 pathogenic -0.018 Destabilizing 0.818 D 0.596 neutral None None None None N
R/E 0.6293 likely_pathogenic 0.6212 pathogenic 0.092 Stabilizing 0.39 N 0.518 neutral None None None None N
R/F 0.6626 likely_pathogenic 0.6834 pathogenic 0.095 Stabilizing 0.39 N 0.59 neutral None None None None N
R/G 0.5187 ambiguous 0.5343 ambiguous -0.195 Destabilizing 0.71 D 0.573 neutral N 0.484504695 None None N
R/H 0.169 likely_benign 0.1574 benign -0.783 Destabilizing 0.818 D 0.589 neutral None None None None N
R/I 0.4051 ambiguous 0.4251 ambiguous 0.754 Stabilizing 0.39 N 0.597 neutral None None None None N
R/K 0.159 likely_benign 0.1505 benign 0.009 Stabilizing 0.002 N 0.147 neutral None None None None N
R/L 0.385 ambiguous 0.4065 ambiguous 0.754 Stabilizing 0.003 N 0.294 neutral N 0.501197842 None None N
R/M 0.4478 ambiguous 0.4457 ambiguous 0.134 Stabilizing 0.818 D 0.621 neutral None None None None N
R/N 0.7093 likely_pathogenic 0.7247 pathogenic 0.221 Stabilizing 0.561 D 0.548 neutral None None None None N
R/P 0.9314 likely_pathogenic 0.943 pathogenic 0.549 Stabilizing 0.946 D 0.599 neutral N 0.449750301 None None N
R/Q 0.1998 likely_benign 0.1901 benign 0.202 Stabilizing 0.844 D 0.536 neutral N 0.490575416 None None N
R/S 0.6584 likely_pathogenic 0.6723 pathogenic -0.121 Destabilizing 0.561 D 0.567 neutral None None None None N
R/T 0.3854 ambiguous 0.3868 ambiguous 0.151 Stabilizing 0.561 D 0.565 neutral None None None None N
R/V 0.4444 ambiguous 0.4675 ambiguous 0.549 Stabilizing 0.39 N 0.573 neutral None None None None N
R/W 0.2886 likely_benign 0.2725 benign 0.106 Stabilizing 0.972 D 0.576 neutral None None None None N
R/Y 0.5368 ambiguous 0.5298 ambiguous 0.489 Stabilizing 0.007 N 0.291 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.